Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SER-287
DRUG
2 trials
Sponsors
Seres Therapeutics, Inc.
Conditions
Ulcerative Colitis
Phase 1
A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
Completed
NCT02618187
Seres Therapeutics, Inc.
Ulcerative Colitis
Start: 2016-01-13
End: 2018-01-26
Updated: 2019-06-20
Phase 2
A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Terminated
NCT03759041
Seres Therapeutics, Inc.
Ulcerative Colitis
Start: 2018-12-19
End: 2021-10-13
Updated: 2022-08-12
Related Papers
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.
2020-08-04
86 citations